Bryxta 100 Injection Bryxta 100 is a bevacizumab-based targeted anticancer injection that works by blocking vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels. By reducing the blood supply that tumors need to grow and spread, bevacizumab can help slow cancer progression. It is administered by intravenous infusion under specialist medical supervision.